Increased protein expression of LHCG receptor and 17-hydroxylase/17-20- lyase in human polycystic ovaries

Human Reproduction

Volumn 28, Issue 11, 2013, Pages 3086-3092

  Comim, F V ^a,c   Teerds, K ^b   Hardy, K ^a   Franks, S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

17 hydroxylase 17 20 lyase; LHCG receptor; ovarian steroidogenesis; polycystic ovary syndrome; theca cells

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 5; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; 3BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2; LHCG RECEPTOR; RECEPTOR; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; OVARY FOLLICLE; OVARY POLYCYSTIC DISEASE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; THECA CELL;

17Α-HYDROXYLASE/17-20-LYASE; LHCG RECEPTOR; OVARIAN STEROIDOGENESIS; POLYCYSTIC OVARY SYNDROME; THECA CELLS;

3-HYDROXYSTEROID DEHYDROGENASES; FEMALE; HUMANS; OVARY; POLYCYSTIC OVARY SYNDROME; RECEPTORS, LH; STEROID 17-ALPHA-HYDROXYLASE;

EID: 84885914992     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/det352     Document Type: Article

References (34)

1. Balen AH, Conway GS, Kaltsas G, Techatrasak K, Manning PJ, West C, Jacobs HS. Polycystic ovary syndrome: The spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107-2111.
2. Bremer AA, Miller WL. The serine phosphorylation hypothesis of polycystic ovary syndrome: A unifying mechanism for hyperandrogenemia and insulin resistance. Fertil Steril 2008;89:1039-1048.
3. Carmina E, Lobo RA. Prevalence and metabolic characteristics of adrenal androgen excess in hyperandrogenic women with different phenotypes. J Endocrinol Invest 2007;30:111-116.
4. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005; 83:1717-1723.
5. Chen ZJ, Zhao H, He L, Shi Y, Qin Y, Li Z, You L, Zhao J, Liu J, Liang X et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet 2011;43:55-59.
6. Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clin Endocrinol 1989;30:459-470.
7. Dharia S, Slane A, Jian M, Conner M, Conley AJ, Parker CR Jr. Colocalization of P450c17 and cytochrome b5 in androgen-synthesizing tissues of the human. Biol Reprod 2004;71:83-88.
8. Diamanti-Kandarakis E. Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications. Expert RevMol Med 2008;10:e3.
9. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-4011.
10. Franks S, Stark J, Hardy K. Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 2008;14:367-378.
11. Gilling-Smith C, Willis DS, Beard RW, Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab 1994;79:1158-1165.
12. Gilling-Smith C, Story H, Rogers V, Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 1997;47:93-99.
13. Gougeon A. Regulation of ovarian follicular development in primates: Facts and hypotheses. Endocr Rev 1996;17:121-155.
14. Hogg K, Young JM,Oliver EM, Souza CJ,McNeillyAS, DuncanWC. Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. Endocrinology 2012;153:450-461.
15. Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab 2001; 86:1318-1323.
16. Kaaijk EM, Sasano H, Suzuki T, Beek JF, van Der Veen F. Distribution of steroidogenic enzymes involved in androgen synthesis in polycystic ovaries: An immunohistochemical study. Mol Hum Reprod 2000; 6:443-447.
17. Kumar A,Woods KS, Bartolucci AA, Azziz R. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2005;62:644-649.
18. Mutharasan P, Galdones E, Penalver Bernabe B, Garcia OA, Jafari N, Shea LD, Woodruff TK, Legro RS, Dunaif A, Urbanek M. Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab 2013; 98:E185-E190.
19. Nelson VL, Legro RS, Strauss JF III, McAllister JM. Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Mol Endocrinol 1999;13:946-957.
20. Papacleovoulou G, Edmondson RJ, Critchley HO, Hillier SG, Mason JI. 3beta-Hydroxysteroid dehydrogenases and pre-receptor steroid metabolism in the human ovarian surface epithelium. Mol Cell Endocrinol 2009;301:65-73.
21. Peters MA, Teerds KJ, van der Gaag I, de Rooij DG, van Sluijs FJ. Use of antibodies against LH receptor, 3beta-hydroxysteroid dehydrogenase and vimentin to characterize different types of testicular tumour in dogs. Reproduction 2001;121:287-296.
22. Schoemaker NJ, Teerds KJ, Mol JA, Lumeij JT, Thijssen JH, Rijnberk A. The role of luteinizing hormone in the pathogenesis of hyperadrenocorticism in neutered ferrets. Mol Cell Endocrinol 2002;197:117-125.
23. Shi Y, Zhao H, Cao Y, Yang D, Li Z, Zhang B, Liang X, Li T, Chen J, Shen J et al. Genome-wide association study identifies eight newrisk loci for polycystic ovary syndrome. Nat Genet 2012;44:1020-1025.
24. Stubbs SA, Hardy K, Da Silva-Buttkus P, Stark J, Webber LJ, Flanagan AM, Themmen AP, Visser JA, Groome NP, Franks S. Anti-Mullerian hormone protein expression is reduced during the initial stages of follicle development in human polycystic ovaries. J Clin Endocrinol Metab 2005; 90:5536-5543.
25. Stubbs SA, Stark J, Dilworth SM, Franks S, Hardy K. Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division. J Clin Endocrinol Metab 2007;92:4418-4426.
26. Takayama K, Fukaya T, Sasano H, Funayama Y, Suzuki T, Takaya R,Wada Y, Yajima A. Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome. HumReprod 1996;11:1387-1392.
27. Tamura T, Kitawaki J, Yamamoto T, Osawa Y, Kominami S, Takemori S, Okada H. Immunohistochemical localization of 17 alpha-hydroxylase/C17-20 lyase and aromatase cytochrome P-450 in the human ovary during the menstrual cycle. J Endocrinol 1992;135:589-595.
28. Teerds KJ, Dorrington JH. Immunolocalization of transforming growth factor alpha and luteinizing hormone receptor in healthy and atretic follicles of the adult rat ovary. Biol Reprod 1995;52:500-508.
29. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S. Formation and early development of follicles in the polycystic ovary. Lancet 2003;362:1017-1021.
30. Wickenheisser JK, Nelson-Degrave VL, McAllister JM. Dysregulation of cytochrome P450 17alpha-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab 2005;90:1720-1727.
31. Wickenheisser JK, Nelson-DeGrave VL, McAllister JM. Human ovarian theca cells in culture. Trends Endocrinol Metab 2006;17:65-71.
32. Willis D, Mason H, Gilling-Smith C, Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 1996;81:302-309.
33. Young JM, McNeilly AS. Theca: The forgotten cell of the ovarian follicle. Reproduction 2010;140:489-504.
34. Zhu JQ, Zhu L, LiangXW, Xing FQ, Schatten H, Sun QY. Demethylation of LHR in dehydroepiandrosterone-induced mouse model of polycystic ovary syndrome. Mol Hum Reprod 2010;16:260-266.